COLORADO SPRINGS, Colo., May 13, 2020 /PRNewswire/ — As the world’s supply chain for pharmaceutical drugs comes under increasing scrutiny for safety and quality, Chromatic Technologies Inc. (CTI) has introduced printable thermochromic technology that is free of Bisphenol A, F and S. The development meets the stringent regulatory standards for pharma packaging.
The spread of the coronavirus has refocused the world’s attention on proper care of the supply chain for vaccines and drugs. Additionally, interest has surged in low-cost technology that monitors the cold chain, identifies temperature abuse and tampering and provides authentication.
Bisphenol A (BPA) has been labeled “an endocrine disruptor,” though it is found in many plastics, the lining of food and beverage cans and carbonless paper. Several companies have attempted to limit Bisphenol A, F and S in order to be more cautious. CTI recognized that effort and has responded with its latest innovation now available to pharmaceutical packaging companies.
CTI’s BlindSpotz™ technology is a portfolio of patented technology that created low-cost printable sensors for drugs that detects freezing, thawing, gradual warming, tampering and authentication.
Pharmaceutical printers, as well as food and beverage printers, are requiring CTI’s innovative thermochromic inks to be free of Bisphenol A, F and S. Heretofore, printers have rejected traditional thermochromics for not meeting strict internal and external regulatory standards.
“We undertook the challenge of reinventing thermochromic technology to meet the high standards of pharmaceutical customers,” said Lyle Small, CTI’s chief executive officer. “Not only did we create CTI’s products free of BPA, F and S, but we also installed a 21-step checklist to validate quality and performance.” For full compliance information, visit www.ctiinks.com.
CTI is the world’s largest supplier of smart, specialty, color-changing technology that responds to temperature, light and pressure. CTI, founded in 1993, exports to 55 countries and is an ISO9001/2015 production facility. CTI’s ink technology is found worldwide on many of the most recognizable brands in the consumer marketplace.
About Chromatic Technologies Inc.
CTI is the world’s largest producer of thermochromic ink and manufactures other environmentally reactive technology, such as photochromic, pressure activated, irreversible, reveal and glow-in-the dark. CTI is an innovation company that supports the world’s biggest brands and package printers. www.ctiinks.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/cti-invents-thermochromic-inks-free-of-bisphenol-a-f-and-s-in-response-to-pharmaceutical-demand-301057260.html
SOURCE Chromatic Technologies Inc.
FRONTIER2 data presented at ISTH 2024 showed that up to 95% of people, who had…
Pemvidutide elicited significant weight loss and decreases in pro-inflammatory serum lipids associated with atherogenesis and…
TAIPEI, June 22, 2024 /PRNewswire/ -- The prestigious 2024 Tang Prize Laureates have been announced,…
Afrezza® Afrezza® (insulin human) Inhalation Powder. Study proves inhaled insulin is as effective as usual…
PURCHASE, NY, June 21, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader…
TERN-501 significantly improved the efficacy of a GLP-1 receptor agonist by normalizing energy expenditure, resulting…